Jun 03, 06
|
| NEW STORY |
| 11:30 ET |
Therion Reports Results of Phase 2 PROSTVAC(R)-VF Trial at ASCO Annual Meeting and Formalizes Plan for an NCI-Sponsored Phase 3 Study
|
|
Jun 01, 06
|
| 08:30 ET |
Therion Biologics Announces Conclusion of PANVAC-VF Phase 3 Trial
|
|
Feb 10, 06
|
| 08:01 ET |
Therion Completes Phase III Enrollment for PANVAC-VF Pancreatic Cancer Trial; BLA Planned for 2006
|
|
Jul 07, 05
|
| 09:53 ET |
Therion Biologics Corporation Completes Enrollment in Phase II Clinical Trial of PROSTVAC(R)-VF in Androgen Independent Prostate Cancer
|
|
| 08:51 ET |
Therion Biologics Corporation Completes Enrollment in Phase II Clinical Trial of PROSTVAC(R)-VF in Androgen Independent Prostate Cancer
|
|
Jun 17, 05
|
| 08:59 ET |
Therion Biologics Corporation Secures $30 Million in Private Equity Financing
|
|
May 11, 05
|
| 09:15 ET |
Therion Announces Upcoming Oral and Poster Presentations at ASCO on Lead Programs in Prostate and Pancreatic Cancer
|
|
Jan 06, 05
|
| 09:20 ET |
Therion Biologics Establishes Clinical Advisory Board to Guide the Development of its Multiple Therapeutic Cancer Vaccine Programs
|
|
Dec 22, 04
|
| 08:02 ET |
Researchers Publish Supporting Safety and Anti-tumor Activity of Therion Biologics' CEA-TRICOM(TM) Therapeutic Vaccine in Journal of Clinical Oncology
|
|
Oct 29, 04
|
| 10:01 ET |
Therion Biologics to Present at Mass Opportunities Biotechnology Investment Conference
|
|
Jul 28, 04
|
| 08:10 ET |
Therion Biologics Named Among Top 15 Emerging Biotech Companies Of 2004
|
|
Jun 21, 04
|
| 08:33 ET |
Therion Biologics Corporation Initiates Phase III Clinical Trial With PANVAC(TM)-VF In Advanced Pancreatic Cancer
|
|